肌少性肥胖与2型糖尿病发病风险:英国生物银行前瞻性队列及里程碑分析
基于英国生物银行479,607名无糖尿病参与者的前瞻性队列,中位随访14.2年,32,948人发生2型糖尿病。肌少性肥胖者2型糖尿病风险最高(HR 3.54,95%CI 3.34-3.74),高于单纯肥胖或单纯肌少症;转为肌少性肥胖(HR 2.90)和持续肌少性肥胖(HR 3.07)均升高风险。
要点
- 肌少性肥胖者2型糖尿病风险显著高于单纯肥胖或单纯肌少症。
- 转为肌少性肥胖和持续肌少性肥胖均与2型糖尿病风险升高相关。
- 建议在2型糖尿病风险分层中整合肌肉健康与肥胖评估。
核心结论
- 肌少性肥胖与2型糖尿病风险升高相关,且风险高于单纯肥胖或单纯肌少症。
研究设计与样本
- 前瞻性队列研究,纳入479,607名无糖尿病的英国生物银行参与者。
- 肌少性肥胖定义基于握力、骨骼肌质量体重比和脂肪质量百分比。
- 采用Cox模型估计风险比,并进行里程碑分析(n=53,107)评估体成分表型转变。
主要发现
- 中位随访14.2年,32,948名参与者发生2型糖尿病。
- 肌少性肥胖者2型糖尿病风险最高(HR 3.54,95%CI 3.34-3.74),高于单纯肥胖或单纯肌少症。
- 转为肌少性肥胖者风险升高(HR 2.90,95%CI 2.07-4.07)。
- 持续肌少性肥胖者风险升高(HR 3.07,95%CI 1.63-5.79)。
临床怎么用
- 在2型糖尿病风险分层中应综合评估肌肉健康与肥胖状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether sarcopenic obesity (SO) is associated with incident type 2 diabetes (T2D) beyond obesity or sarcopenia alone and whether associations differ by sex, age, and transitions in body composition phenotypes over time. RESEARCH DESIGN AND METHODS: We studied 479,607 diabetes-free UK Biobank participants. SO was defined using handgrip strength, skeletal muscle mass-to-weight ratio, and fat mass percentage. Cox models estimated hazard ratios (HRs). A landmark analysis (n = 53,107) examined phenotype transitions. RESULTS: Over a median follow-up of 14.2 years, T2D developed in 32,948 participants. SO conferred the highest risk (HR 3.54 [95% CI 3.34-3.74]), exceeding obesity alone and sarcopenia alone. Transitioning to SO (HR 2.90 [95% CI 2.07-4.07]) and persistent SO (HR 3.07 [95% CI 1.63-5.79]) both elevated risks. CONCLUSIONS: SO was associated with higher T2D risk than obesity or sarcopenia alone, supporting integrated assessment of muscle health and adiposity in T2D risk stratification.
引用
- Guan Z, Stephan BCM, Siervo M, et al. Sarcopenic Obesity and Risk of Incident Type 2 Diabetes: A Prospective Cohort Study and Landmark Analysis From the UK Biobank. Diabetes Care. 2026. PMID: 42439362. doi:10.2337/dc26-0797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。